The American Cancer Society estimates that 11,980 people died from melanoma and 3,190 from other nonepithelial skin cancers in 2011, which is among the fastest rising cancers in the U.S.
Combination antibody therapy shows promise in metastatic melanoma (Science Daily)
A duo of monoclonal antibodies -- ipilimumab and bevacizumab -- each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial.
- About Us
- Skin Cancer
- Member Section